life science

Sector Focus

Biomedical, life science sectors in focus as Biopolis turns 20; CapitaLand revives Science Park Drive

“We spend a lot of effort encouraging many companies to use Singapore as a base, and also try to leverage our investment and R&D.”

In print this week

What could lead to even more orders for Venture?

SINGAPORE (Oct 14): Many customers of Venture Corp are large MNCs. Now and then, there may be merger and merger (M&A) deal involving one of its customers. This can be beneficial to the tech manufacturer too.  

Broker's Calls

Venture’s transformation more than meets the eye

SINGAPORE (Oct 10): A shift in product offerings towards test & measurement, and medical and life science equipment is opening up new opportunities for Venture Corp, says UOB Kay Hian who is sticking to its “buy” call with a higher target price of $10

Broker's Calls

This niche contract manufacturer is the latest to catch CIMB’s attention

SINGAPORE (Sept 8): CIMB Research is initiating coverage of CEI Limited at “add” with a target price of $1.04, with expectations that its medical technology (medtech) and life science business will drive revenue growth of 5% over the FY17-18 forecast
×